MedPath

EBUS-TBNA-RTE VS Radiography in Staging of NSCLC

Not Applicable
Conditions
Lung Cancer
Interventions
Device: EBUS-TBNA-RTE
Registration Number
NCT03392506
Lead Sponsor
Jiayuan Sun
Brief Summary

The purpose of this study is to make a qualitative and quantitative analysis of the intrathoracic lymph nodes by CP-EBUS elastography for the first time, and to make a benign and malignant diagnosis.

Detailed Description

The newly developed convex array can be used to identify the hardness of the lymph nodes and estimate the benign and malignant lymph nodes indirectly through the quantitative and visualized analysis of the elastic coefficient of the bronchus through the CP-EBUS elastography mode.

The purpose of this study is to make a qualitative and quantitative analysis of the intrathoracic lymph nodes by CP-EBUS elastography for the first time, and to make a benign and malignant diagnosis.

120cases will be enrolled.Compared with the commonly used methods to evaluate intrathoracic lymph node metastasis, the accuracy of chest CT and PET-CT were compared. The lymph node staging method and the final pathological gold standard of the three groups were compared, so as to verify the accuracy and clinical popularization of the bronchial ultrasound elastography mode.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. Intrathoracic lymph node enlargement
  2. EBUS-TBNA operation can be performed
Exclusion Criteria
  1. Unable to cooperate with the experiment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
EBUS-TBNA-RTEEBUS-TBNA-RTEPatients do CT、 PETCT examination and EBUS-TBNA-RTE
Primary Outcome Measures
NameTimeMethod
The effectiveness of EBUS-TBNA-RTE1year

By comparison of the diagnostic accuracy of CT ,PET-CT and EBUS-TBNA-RTE

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath